DMAC vs WBD · $157.4M cap vs rev $39.32B
DiaMedica Therapeutics Inc (DMAC) versus Warner Bros Discovery Inc (WBD) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Warner Bros Discovery Inc (WBD) is a entertainment company listed on NASDAQ.
DMAC does not have a complete income-statement cache yet.
Latest reported WBD revenue for 2024-12-31 was $39.32B. Net income was -$11.48B. Revenue was down 4.8% from 2023-12-31 to 2024-12-31. WBD currently screens at market cap $66.93B.
DMAC currently screens at market cap $157.4M. WBD currently screens at market cap $66.93B.
Not investment advice. Open the DMAC and WBD stock pages for the full models.
Not investment advice.